Endocannabinoid system

• One-stop Microfluidic Assembly of Human Brain Organoids to Model Prenatal Cannabis Exposure (30 Sep 2024)
  
• Sex and Gender Interactions on the Use and Impact of Recreational Cannabis (26 Sep 2024)
  
• The (endo)cannabinoid signaling in female reproduction: What are the latest advances? (24 Sep 2024)
  
• The Role of Cannabinoids in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2020 (16 Sep 2024)
  
• Omega-6 and omega-3 fatty acids: Endocannabinoids, genetics and obesity (16 Sep 2024)
  
• Medical cannabis for orthopaedic patients with chronic musculoskeletal pain: does evidence support its use? (16 Sep 2024)
  
• Different Effects of Cannabis Abuse on Adolescent and Adult Brain (16 Sep 2024)
  
• Chemical Characteristics, Therapeutic Uses, and Legal Aspects of the Cannabinoids of Cannabis sativa: A Review (16 Sep 2024)
  
• Changing the Tone of Clinical Study Design in the Cannabis Industry (16 Sep 2024)
  
• Cannabis hyperemesis syndrome: an update on the pathophysiology and management (16 Sep 2024)
  
• Cannabis as a Gateway Drug for Opioid Use Disorder (16 Sep 2024)
  
• Hypothalamic cannabinoid signaling: Consequences for eating behavior (03 Sep 2024)
  
• Comparing CB1 receptor GIRK channel responses to receptor internalization using a kinetic imaging assay (03 Sep 2024)
  
• Cannabinoids and triple-negative breast cancer treatment (03 Sep 2024)
  
• Cannabinoids and monoaminergic system: implications for learning and memory (03 Sep 2024)
  
• Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine (02 Sep 2024)
  
• Tumor necrosis factor α, and agonist and antagonists of cannabinoid receptor type 1 and type 2 alter the immunophenotype of stem cells from human exfoliated deciduous teeth (02 Sep 2024)
  
• Therapeutic Application of Modulators of Endogenous Cannabinoid System in Parkinson’s Disease (02 Sep 2024)
  
• The Sobering Sting: Oleoyl Serotonin Is a Novel Stephanoconus Snail Venom-Derived Antagonist of Cannabinoid Receptors That Counteracts Learning and Memory Deficits (02 Sep 2024)
  
• The Relationship between Muscarinic and Cannabinoid Receptors in Neuronal Excitability and Epilepsy: A Review (02 Sep 2024)
  
• The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer’s Disease (02 Sep 2024)
  
• The Implications of Cannabinoid-Induced Metabolic Dysregulation for Cellular Differentiation and Growth (02 Sep 2024)
  
• Saturated Cannabinoids: Update on Synthesis Strategies and Biological Studies of These Emerging Cannabinoid Analogs (02 Sep 2024)
  
• Role of the CB2 Cannabinoid Receptor in the Regulation of Food Intake: A Systematic Review (02 Sep 2024)
  
• Research progress on the cannabinoid type-2 receptor and Parkinson’s disease (02 Sep 2024)
  
• Prenatal cannabinoid exposure: why expecting individuals should take a pregnancy pause from using cannabinoid products (02 Sep 2024)
  
• Prenatal cannabinoid exposure and early language development (02 Sep 2024)
  
• Potential of CBD Acting on Cannabinoid Receptors CB1 and CB2 in Ischemic Stroke (02 Sep 2024)
  
• Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRABeCB2.0 Sensor (02 Sep 2024)
  
• Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1–aging and epigenomics (02 Sep 2024)
  
• Motifs in Natural Products as Useful Scaffolds to Obtain Novel Benzo[d]imidazole-Based Cannabinoid Type 2 (CB2) Receptor Agonists (02 Sep 2024)
  
• Hexahydrocannabinol (HHC) and Δ9-tetrahydrocannabinol (Δ9-THC) driven activation of cannabinoid receptor 1 results in biased intracellular signaling (02 Sep 2024)
  
• Hemp Seed Oil Inhibits the Adipogenicity of the Differentiation-Induced Human Mesenchymal Stem Cells through Suppressing the Cannabinoid Type 1 (CB1) (02 Sep 2024)
  
• Expression of Cannabinoid Receptors in the Trigeminal Ganglion of the Horse (02 Sep 2024)
  
• Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity (02 Sep 2024)
  
• Editorial: Insights on cannabinoid translational science and medicine: the endocannabinoidome as a target for clinical practice (02 Sep 2024)
  
• Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer’s Disease (02 Sep 2024)
  
• Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality (02 Sep 2024)
  
• Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders (02 Sep 2024)
  
• Overexpression of cannabinoid receptor 2 is associated with human breast cancer proliferation, apoptosis, chemosensitivity and prognosis via the PI3K/Akt/mTOR signaling pathway (30 Aug 2024)
  
• A collection of cannabinoid-related negative findings from autaptic hippocampal neurons (30 Aug 2024)
  
• The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Colon Cancer: A Study in Mice and Humans (29 Aug 2024)
  
• Role of neuronal nicotinic acetylcholine receptors in cannabinoid dependence ☆ (29 Aug 2024)
  
• Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling (29 Aug 2024)
  
• Hippocampal expression of the cannabinoid receptor type 1 in canine epilepsy (29 Aug 2024)
  
• Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPARα) in the synovial membrane of the horse metacarpophalangeal joint (29 Aug 2024)
  
• Endocannabinoid administration affects taste preference and the expression of cannabinoid and opioid receptors in the amygdala of early lactating cows (29 Aug 2024)
  
• Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation (29 Aug 2024)
  
• Cannabinoid Signaling in Kidney Disease (29 Aug 2024)
  
• Cannabinoid and Opioid Receptor Affinity and Modulation of Cancer-Related Signaling Pathways of Machaeriols and Machaeridiols from Machaerium Pers. (29 Aug 2024)
  
• The endocannabinoid systemʼs involvement in motor development relies on cannabinoid receptors, TRP channels, and Sonic Hedgehog signaling (28 Aug 2024)
  
• Role of Endo-opioid and Endo-cannabinoid Systems in Migraine and Medication-overuse Headache (28 Aug 2024)
  
• Microglial Cannabinoid CB2 Receptors in Pain Modulation (28 Aug 2024)
  
• Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases (28 Aug 2024)
  
• Therapeutic Use of Cannabis in Inflammatory Bowel Disease (27 Aug 2024)
  
• The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease (27 Aug 2024)
  
• The Enteric Glia and Its Modulation by the Endocannabinoid System, a New Target for Cannabinoid-Based Nutraceuticals? (27 Aug 2024)
  
• Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease (27 Aug 2024)
  
• Molecular Insights into Epigenetics and Cannabinoid Receptors (27 Aug 2024)
  
• Evaluation of cannabinoid receptors type 1–2 in periodontitis patients (27 Aug 2024)
  
• Cannabinoid receptors in the inflammatory cells of canine atopic dermatitis (27 Aug 2024)
  
• Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential (27 Aug 2024)
  
• A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis—Clinical Implications (27 Aug 2024)
  
• A Critical Evaluation of Terpenoid Signaling at Cannabinoid CB1 Receptors in a Neuronal Model (27 Aug 2024)
  
• Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease (25 Aug 2024)
  
• The cannabinoid receptors system in horses: Tissue distribution and cellular identification in skin (25 Aug 2024)
  
• Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells (25 Aug 2024)
  
• Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders (25 Aug 2024)
  
• Distribution of Cannabinoid Receptors in Keratinocytes of Healthy Dogs and Dogs With Atopic Dermatitis (25 Aug 2024)
  
• Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance (25 Aug 2024)
  
• Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits (25 Aug 2024)
  
• Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report (25 Aug 2024)
  
• Activation of cannabinoid receptors in breast cancer cells improves osteoblast viability in cancer-bone interaction model while reducing breast cancer cell survival and migration (25 Aug 2024)
  
• Roles of the Cannabinoid System in the Basal Ganglia in Parkinson’s Disease (21 Aug 2024)
  
• New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders (21 Aug 2024)
  
• Interplay between the Cannabinoid System and microRNAs in Cancer (21 Aug 2024)
  
• Impact of Cannabinoid Compounds on Skin Cancer (21 Aug 2024)
  
• Therapeutic potential of the cannabinoid receptor 2 in neuropsychiatry (20 Aug 2024)
  
• Reversing the Psychiatric Effects of Neurodevelopmental Cannabinoid Exposure: Exploring Pharmacotherapeutic Interventions for Symptom Improvement (20 Aug 2024)
  
• Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R) (20 Aug 2024)
  
• Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities (20 Aug 2024)
  
• Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review (20 Aug 2024)
  
• On the Role of Central Type-1 Cannabinoid Receptor Gene Regulation in Food Intake and Eating Behaviors (20 Aug 2024)
  
• Neural Substrates of Incidental Associations and Mediated Learning: The Role of Cannabinoid Receptors (20 Aug 2024)
  
• Metabolic Consequences of Gestational Cannabinoid Exposure (20 Aug 2024)
  
• Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases (20 Aug 2024)
  
• Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response (20 Aug 2024)
  
• Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment (20 Aug 2024)
  
• Cannabinoid Signaling in Auditory Function and Development (20 Aug 2024)
  
• Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases (20 Aug 2024)
  
• Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma (20 Aug 2024)
  
• Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease (20 Aug 2024)
  
• Cannabinoid receptor gene polymorphisms and cognitive performance in patients with schizophrenia and controls (20 Aug 2024)
  
• Cannabinoid Receptor 2 Alters Social Memory and Microglial Activity in an Age-Dependent Manner (20 Aug 2024)
  
• Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox (20 Aug 2024)
  
• Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease (20 Aug 2024)
  
• Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment (20 Aug 2024)
  
• Cannabinoid Control of Olfactory Processes: The Where Matters (20 Aug 2024)
  
• Associations Among Parental Caregiving Quality, Cannabinoid Receptor 1 Expression-Based Polygenic Scores, and Infant-Parent Attachment: Evidence for Differential Genetic Susceptibility? (20 Aug 2024)
  
• Alterations in Brain Cannabinoid Receptor Levels Are Associated with HIV-Associated Neurocognitive Disorders in the ART Era: Implications for Therapeutic Strategies Targeting the Endocannabinoid System (20 Aug 2024)
  
• A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid (20 Aug 2024)
  
• The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity (19 Aug 2024)
  
• Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease (19 Aug 2024)
  
• Interaction between cannabinoid and nucleotide systems as a new mechanism of signaling in retinal cell death (19 Aug 2024)
  
• Down-Regulation of Cannabinoid Type 1 (CB1) Receptor and its Downstream Signaling Pathways in Metastatic Colorectal Cancer (19 Aug 2024)
  
• Comparative evaluation of cannabinoid receptors, apelin and S100A6 protein in the heart of women of different age groups (19 Aug 2024)
  
• Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System (19 Aug 2024)
  
• Cannabinoid Delivery Systems for Pain and Inflammation Treatment (19 Aug 2024)
  
• Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology (19 Aug 2024)
  
• Antitumor Cannabinoid Chemotypes: Structural Insights (19 Aug 2024)
  
• Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation (19 Aug 2024)
  
• Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges (18 Aug 2024)
  
• Synthesis, Biodistribution and In vitro Evaluation of Brain Permeable High Affinity Type 2 Cannabinoid Receptor Agonists [11C]MA2 and [18F]MA3 (18 Aug 2024)
  
• Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system (18 Aug 2024)
  
• Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics (18 Aug 2024)
  
• Focus on the Endogenous Cannabinoid System in Migraine (18 Aug 2024)
  
• Effect of interaction between acute administration of morphine and cannabinoid compounds on spontaneous excitatory and inhibitory postsynaptic currents of magnocellular neurons of supraoptic nucleus (18 Aug 2024)
  
• Culture and cannabinoid receptor gene polymorphism interact to influence the perception of happiness (18 Aug 2024)
  
• CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease (18 Aug 2024)
  
• Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System (18 Aug 2024)
  
• Cannabinoid receptor type-1: breaking the dogmas (18 Aug 2024)
  
• Cannabinoid Modulation of the Stressed Hippocampus (18 Aug 2024)
  
• Cannabinoid CB2 Receptor Gene and Environmental Interaction in the Development of Psychiatric Disorders (18 Aug 2024)
  
• Cannabinoid CB1 Receptors Are Localized in Striated Muscle Mitochondria and Regulate Mitochondrial Respiration (18 Aug 2024)
  
• Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy (18 Aug 2024)
  
• The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons (12 Aug 2024)
  
• Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation (12 Aug 2024)
  
• Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder (12 Aug 2024)
  
• Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use (24 May 2024)
  
• Inflammation and cancer: friend or foe? (24 May 2024)
  
• Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer (24 May 2024)
  
• The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review (13 May 2024)
  
• Effect of the Cannabinoid Receptor-1 antagonist SR141716A on human adipocyte inflammatory profile and differentiation (13 May 2024)
  
• Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy (13 May 2024)
  
• Cannabinoid Receptor 1 Blockade Attenuates Obesity and Adipose Tissue Type 1 Inflammation Through miR-30e-5p Regulation of Delta-Like-4 in Macrophages and Consequently Downregulation of Th1 Cells (13 May 2024)
  
• Zebrafish as an Animal Model in Cannabinoid Research (02 Sep 2023)
  
• Role of the Endocannabinoid System in Metabolic Control Processes and in the Pathogenesis of Metabolic Syndrome: An Update (27 Feb 2023)
  
• Endocannabinoid System: Chemical Characteristics and Biological Activity (27 Feb 2023)
  
• Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review (27 Feb 2023)
  
• Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies (27 Feb 2023)
  
• The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells (05 Sep 2022)
  
• The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies (05 Sep 2022)
  
• Quality of Life and a Surveillant Endocannabinoid System (05 Sep 2022)
  
• Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors? (05 Sep 2022)
  
• Kahweol, a natural diterpene from coffee, induces peripheral antinociception by endocannabinoid system activation (05 Sep 2022)
  
• Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses (01 Sep 2022)
  
• Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis (01 Sep 2022)
  
• Editorial: Challenges and Conundrums in Cannabinoid-Based Treatments for Epilepsy Syndromes and Associated Neurobehavioral Comorbidities (01 Sep 2022)
  
• Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression (27 Aug 2022)
  
• New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence (27 Aug 2022)
  
• Inhibition of Nociception in a Preclinical Episodic Migraine Model by Dietary Supplementation of Grape Seed Extract Involves Activation of Endocannabinoid Receptors (27 Aug 2022)
  
• Enhancing Endocannabinoid Control of Stress with Cannabidiol (27 Aug 2022)
  
• Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition (13 Aug 2022)
  
• Considerations for Cannabinoids in Perioperative Care by Anesthesiologists (13 Aug 2022)
  
• Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation (13 Aug 2022)
  
• The Mediterranean Diet as a Source of Bioactive Molecules with Cannabinomimetic Activity in Prevention and Therapy Strategy (07 Aug 2022)
  
• The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation (05 Aug 2022)
  
• Targeting the Endocannabinoidome in Pancreatic Cancer (05 Aug 2022)
  
• Endocannabinoid-Mediated Control of Neural Circuit Excitability and Epileptic Seizures (05 Aug 2022)
  
• Dos(e)Age: Role of Dose and Age in the Long-Term Effect of Cannabinoids on Cognition (05 Aug 2022)
  
• Chronic Pain and the Endocannabinoid System: Smart Lipids – A Novel Therapeutic Option? (05 Aug 2022)
  
• Cannabinoids, their cellular receptors, and effects on the invasive phenotype of carcinoma and metastasis (05 Aug 2022)
  
• Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action (31 Jul 2022)
  
• Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report - Journal of Medical Case Reports (31 Jul 2022)
  
• Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function (31 Jul 2022)
  
• Endocannabinoid System and Migraine Pain: An Update (25 Jul 2022)
  
• Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review (21 Jul 2022)
  
• Endocannabinoid Discovery Timeline (21 Jul 2022)
  
• What is CBD? Definition of Cannabidiol & CBD Oil (20 Jul 2022)
  
• Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease (20 Jul 2022)
  
• What Is CBC Oil Good For? Benefits, Uses, & Effects (18 Jul 2022)
  
• What are cannabinoids CBN, CBC, CBG and THCV? (18 Jul 2022)
  
• The Role of Cannabinoid Receptors (18 Jul 2022)
  
• Guide to Cannabinoids: Understanding the Endocannabinoid System (18 Jul 2022)
  
• Endocannabinoid System (18 Jul 2022)